# 一个用以描述超高剂量率下细胞存活反应的多尺度辐射生物物理随机模型

发布时间：2024年12月20日

`其他`

> A multiscale radiation biophysical stochastic model describing the cell survival response at ultra-high dose rate

# 摘要

> 超超高剂量率（UHDR）放疗，其辐射输送率极高，是放疗领域最新且极具前景的前沿方向之一。在该领域被称作 FLASH 放疗的 UHDR 放疗，是一种创新性的治疗模式，具有诸多优势，比如治疗时间大幅缩短、治疗肿瘤的效果不变以及正常组织副作用显著减少。尽管 UHDR 照射的优点在实验中已被重点强调，但 FLASH 效应背后的生物学机制仍不明晰且争议颇大。然而，要在临床上有效运用 UHDR 放疗，理解其驱动的生物学机制至关重要。鉴于多个尺度的辐射损伤被认为同时参与其中，我们开发了多尺度广义随机微剂量学模型（MS-GSM2），它是 GSM2 的多阶段扩展，是一个描述受照细胞核中 DNA 损伤时间演变的概率模型。MS-GSM2 能够研究多种化学物质的联合效应、DNA 损伤的形成及时间演变。我们证实，MS-GSM2 能够预测不同氧合水平、辐射类型和能量下的多种体外 UHDR 实验结果。MS-GSM2 能够精准描述在广泛范围内剂量和剂量率依赖的细胞敏感性的经验趋势，全面阐述 FLASH 效应的多个方面，并重现体外实验数据中的主要证据。我们的模型还为体内、体外正常组织和肿瘤中观察到的不同结果给出了一致的解释。

> Ultra-high dose-rate (UHDR) radiotherapy, characterized by an extremely high radiation delivery rate, represents one of the most recent and promising frontier in radiotherapy. UHDR radiotherapy, addressed in the field as FLASH radiotherapy, is a disruptive treatment modality with several benefits, including significantly shorter treatment times, unchanged effectiveness in treating tumors, and clear reductions in side effects on normal tissues. While the benefits of UHDR irradiation have been well highlighted experimentally, the biological mechanism underlying the FLASH effect is still unclear and highly debated. Nonetheless, to effectively use UHDR radiotherapy in clinics, understanding the driving biological mechanism is paramount. Since the concurrent involvement of multiple scales of radiation damage has been suggested, we developed the MultiScale Generalized Stochastic Microdosimetric Model (MS-GSM2), a multi-stage extension of the GSM2, which is a probabilistic model describing the time evolution of the DNA damage in an irradiated cell nucleus. The MS-GSM2 can investigate several chemical species combined effects, DNA damage formation, and time evolution. We demonstrate that the MS-GSM2 can predict various in-vitro UHDR experimental results across various oxygenation levels, radiation types, and energies. The MS-GSM2 can accurately describe the empirical trend of dose and dose rate-dependent cell sensitivity over a wide range, consistently describing multiple aspects of the FLASH effect and reproducing the main evidence from the in-vitro experimental data. Our model also proposes a consistent explanation for the differential outcomes observed in normal tissues and tumors, in-vivo and in-vitro.

[Arxiv](https://arxiv.org/abs/2412.16322)